Clinical benefits of leukodepleted blood products:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Austin
Landes u.a.
1995
|
Schriftenreihe: | Medical intelligence unit
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Literaturangaben |
Beschreibung: | 198 S. Ill., graph. Darst. |
ISBN: | 3540588930 1570591229 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV010211666 | ||
003 | DE-604 | ||
005 | 19950831 | ||
007 | t | ||
008 | 950530s1995 gw ad|| |||| 00||| eng d | ||
016 | 7 | |a 944297048 |2 DE-101 | |
020 | |a 3540588930 |9 3-540-58893-0 | ||
020 | |a 1570591229 |9 1-57059-122-9 | ||
035 | |a (OCoLC)31378407 | ||
035 | |a (DE-599)BVBBV010211666 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
044 | |a gw |c DE | ||
049 | |a DE-355 | ||
050 | 0 | |a RM171.4 | |
082 | 0 | |a 615/.39 |2 20 | |
084 | |a YU 1800 |0 (DE-625)154189:12905 |2 rvk | ||
245 | 1 | 0 | |a Clinical benefits of leukodepleted blood products |c Joseph Sweeney ... |
264 | 1 | |a Austin |b Landes u.a. |c 1995 | |
300 | |a 198 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Medical intelligence unit | |
500 | |a Literaturangaben | ||
650 | 7 | |a Bloedtransfusie |2 gtt | |
650 | 7 | |a Leukocyten |2 gtt | |
650 | 4 | |a Blood Component Transfusion |x adverse effects | |
650 | 4 | |a Cell Separation |x methods | |
650 | 4 | |a Leucocyte-poor blood products | |
650 | 4 | |a Leukocytes |x immunology | |
650 | 0 | 7 | |a Blut |0 (DE-588)4007259-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Leukapherese |0 (DE-588)4238349-3 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Blut |0 (DE-588)4007259-9 |D s |
689 | 0 | 1 | |a Leukapherese |0 (DE-588)4238349-3 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Sweeney, Joseph |e Sonstige |4 oth | |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006785911&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-006785911 |
Datensatz im Suchindex
_version_ | 1808228104195276800 |
---|---|
adam_text |
YY
CONTENTS
-
.
1.
INTRODUCTION
.
1
JOSEPH
SWEENEY,
ANDREW
HEATON
2.
METHODS
OF
LEUKODEPLETION
.
5
BARRY
WENZ
SUMMARY
.
5
INDICATIONS
.
6
SEDIMENTATION
.
8
CENTRIFUGATION
.
9
RED
BLOOD
CELL
WASHING
.
9
FROZEN-THAWED
WASHED
RED
BLOOD
CELLS
.
10
LABORATORY
FILTRATION
.
10
BEDSIDE
FILTRATION
.
11
UV
IRRADIATION
.
11
LEUKOCYTE
DEPLETED
APHERESIS
PLATELETS
.
12
TOP
AND
BOTTOM
SYSTEM
.
12
CONCLUSIONS
.
13
3.
ENUMERATION
OF
LOW
WHITE
CELLS
.17
GIROLAMO
SIRCHIA,
PAOLO
REBULLA
SUMMARY
.
17
INTRODUCTION
.
18
THEORETICAL
BACKGROUND
.
18
METHODS FOR
COUNTING
WBC
IN
LDBC
.
20
QUALITY
CONTROL
OF
LDBC
.
23
CONCLUSIONS
.
24
4.
MECHANISMS
OF
LEUKODEPLETION
BY
FILTRATION
.
29
INGEBORG
STENEKER,
R.N.I.
PIETERSZ,
HENK
REESINK
SUMMARY
.
29
INTRODUCTION
.
30
FILTRATION
PROCESSES
.
30
FACTORS
INFLUENCING
BLOOD
CELL
FILTRATION
BY
DEPTH
FILTERS
.
31
CONCLUSION
.
39
5.
ROLE
OF
CONTAMINATING
WHITE
BLOOD
CELLS
IN
THE
STORAGE
LESIONS
OF
RED
CELLS
AND
PLATELETS
.
43
JOSEPH
D.
SWEENEY,
STEIN
HOLME,
W.
ANDREW
HEATON
SUMMARY
.
43
RED
CELL
CONCENTRATES
.
44
PLATELET
PREPARATIONS
.
49
CONCLUSIONS
.
55
6.
LEUKODEPLETION
TO
PREVENT
TRANSFUSION
REACTIONS:
EFFECTS
ON
CYTOKINES
AND
OTHER
BIOLOGIC
RESPONSE
MODIFIERS
.
61
GARY
STACK,
EDWARD
L.
SNYDER
SUMMARY
.
61
INTRODUCTION
.
62
TRALI
.
71
SEPSIS
.
72
TA-GVHD
.
74
CONCLUSIONS
.
74
7.
LEUKODEPLETION
AND
ALLOIMMUNIZATION
.
81
IRENA
SNIECINSKI
SUMMARY
.
81
INTRODUCTION
.
81
MECHANISMS
OF
ALLOIMMUNIZATION
.
82
CLINICAL
CONSEQUENCES
OF
ALLOIMMUNIZATION
.
83
PREVENTION
OF
ALLOIMMUNIZATION
.
84
LEUKODEPLETION
STUDIES
.
85
UNRANDOMIZED
CLINICAL
TRIALS
.
87
PROSPECTIVE
RANDOMIZED
LEUKODEPLETION
TRIALS
.
87
LEUKOCYTE
DOSE
AND
ALLOIMMUNIZATION
.
90
PREVENTION
OF
ALLOIMMUNIZATION
BY
UV-B
IRRADIATION
.
90
CONCLUSION
.
92
8.
ROLE
OF
DONOR
LEUKOCYTES
AND
LEUKODEPLETION
IN
TRANSFUSION-ASSOCIATED
VIRAL
INFECTIONS
.
97
MICHAEL
P.
BUSCH,
TZONG-HAE
LEE
SUMMARY
.
97
DUAL
ROLE
OF
DONOR
LEUKOCYTES
IN
TRANSMISSION
OF
VIRUSES
.
98
EVIDENCE
THAT
LEUKODEPLETION
WILL
REDUCE
THE
RISK
OF
VIRUS
TRANSMISSION
.
102
DONOR
LEUKOCYTE-INDUCED
REACTIVATION
OF
RECIPIENT
VIRAL
INFECTIONS
.
105
CONCLUSIONS
.
108
9.
LEUKOCYTE
DEPLETION
AND
TRANSFUSION-INDUCED
IMMUNOMODULATION
.
113
DARRELL
J.
TRIULZI,
NEIL
BLUMBERG
SUMMARY
.
113
INTRODUCTION
.
114
TRANSPLANTATION
.
114
POSTOPERATIVE
BACTERIAL
INFECTION
.
115
CANCER
RECURRENCE
.
117
PROGRESSION
OR
REACTIVATION
OFVIRAL
INFECTION
.
121
CONCLUSIONS
.
121
10.
THE
ROLE
OF
LEUKOCYTE
DEPLETION
IN
PREVENTION
OF
TRANSFUSION-RELATED
ACUTE
LUNG
INJURY
.
129
MARK
A.
POPOVSKY
SUMMARY
.
129
CLINICAL
DESCRIPTION
.
130
FREQUENCY
.
130
IMPLICATED
BLOOD
PRODUCTS
.
131
PATHOGENESIS
.
131
DIAGNOSIS
.
132
AT
RISK
POPULATION
.
132
ROLE
OF
LEUKOCYTE
DEPLETION
.
133
CONCLUSION
.
133
11.
THE
ROLE
OF
LEUKOCYTE
DEPLETION
IN
THE
PREVENTION
OF
REPERFUSION
INJURY
ASSOCIATED
WITH
OPEN
HEART
SURGERY
.
137
TERRY
GOURLAY,
KENNETH
M.
TAYLOR
SUMMARY
.
137
INTRODUCTION
.
137
HEMODYNAMICS
DURING
CARDIOPULMONARY
BYPASS
.
138
LEUKOCYTE
ACTIVATION
DURING
CARDIOPULMONARY
BYPASS
.
139
PREVENTING
REPERFUSION
INJURY
.
141
LEUKODEPLETION
OF
THE
EXTRACORPOREAL
CIRCUIT
.
144
LEUKOCYTE
DEPLETION
OF
CARDIOPLEGIC
BLOOD
.
146
LEUKODEPLETION
OF
TRANSFUSED
BLOOD
.
146
CONCLUSIONS
.148
12.
THE
USE
OF
LEUKODEPLETED
BLOOD
COMPONENTS
FOR
NEONATES
AND
INFANTS
.
153
NAOMI
L.
C.
LUBAN,
LOUIS
DEPALMA
SUMMARY
.
153
INTRODUCTION
.
153
IMMUNE
MODULATION
.
154
ALLOIMMUNIZATION
TO
BLOOD
CELL
ANTIGENS
.
156
GRAFT
VERSUS
HOST
DISEASE
.
157
CYTOMEGALOVIRUS
.
159
ACTIVATION
OF
LEUKOCYTES
IN
CARDIOPULMONARY
BYPASS
.
160
FEBRILE
TRANSFUSION
REACTIONS
.
161
CONCLUSIONS
.
162
13.
LEUKOCYTE
DEPLETED BLOOD
TRANSFUSION
IN
HEMATOPOIETIC
STEM
CELL
RECONSTITUTION THERAPY
.
167
JOHN
P.
MILLER,
PAUL
D.
MINTZ
SUMMARY
.
167
INTRODUCTION
.
168
PREVENTION
OF
FEBRILE
REACTIONS
(FNTRS)
.
168
PREVENTION
OF
PLATELET
REFRACTORINESS
.
170
PREVENTION
OF
CYTOMEGALOVIRUS
BY
TRANSFUSION
.173
PREVENTION
OF
BACTERIAL
GROWTH
AND
TRANSFUSION
BY
PRE-STORAGE
FILTRATION
.175
PREVENTION
OF
GRAFT-VERSUS-HOST
DISEASE
.
175
OTHER
POTENTIAL
EFFECTS
OF
ALLOGENEIC
LEUKOCYTES
.
176
CONCLUSION
.
176
14.
COST-EFFECTIVENESS
OF
LEUKODEPLETION
.
183
JOHN
M.FORBES,
MAREN
A.
ANDERSON,
STEVEN
A.
GOULD
SUMMARY
.183
INTRODUCTION
.183
DEFINING
TRANSFUSION
COSTS
.
184
THE
COSTS
OF
LEUKODEPLETED
BLOOD
COMPONENTS
.185
QUANTIFYING
THE
BENEFITS
OF
LEUKODEPLETION
.
187
CONCLUSIONS
.
'.
.
190
INDEX
.
193 |
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV010211666 |
callnumber-first | R - Medicine |
callnumber-label | RM171 |
callnumber-raw | RM171.4 |
callnumber-search | RM171.4 |
callnumber-sort | RM 3171.4 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | YU 1800 |
ctrlnum | (OCoLC)31378407 (DE-599)BVBBV010211666 |
dewey-full | 615/.39 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.39 |
dewey-search | 615/.39 |
dewey-sort | 3615 239 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV010211666</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19950831</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">950530s1995 gw ad|| |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">944297048</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540588930</subfield><subfield code="9">3-540-58893-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1570591229</subfield><subfield code="9">1-57059-122-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)31378407</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010211666</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM171.4</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.39</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YU 1800</subfield><subfield code="0">(DE-625)154189:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical benefits of leukodepleted blood products</subfield><subfield code="c">Joseph Sweeney ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Austin</subfield><subfield code="b">Landes u.a.</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">198 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Medical intelligence unit</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bloedtransfusie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Leukocyten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood Component Transfusion</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cell Separation</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leucocyte-poor blood products</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leukocytes</subfield><subfield code="x">immunology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Blut</subfield><subfield code="0">(DE-588)4007259-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Leukapherese</subfield><subfield code="0">(DE-588)4238349-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Blut</subfield><subfield code="0">(DE-588)4007259-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Leukapherese</subfield><subfield code="0">(DE-588)4238349-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sweeney, Joseph</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006785911&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006785911</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV010211666 |
illustrated | Illustrated |
indexdate | 2024-08-24T00:51:40Z |
institution | BVB |
isbn | 3540588930 1570591229 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006785911 |
oclc_num | 31378407 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 198 S. Ill., graph. Darst. |
publishDate | 1995 |
publishDateSearch | 1995 |
publishDateSort | 1995 |
publisher | Landes u.a. |
record_format | marc |
series2 | Medical intelligence unit |
spelling | Clinical benefits of leukodepleted blood products Joseph Sweeney ... Austin Landes u.a. 1995 198 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Medical intelligence unit Literaturangaben Bloedtransfusie gtt Leukocyten gtt Blood Component Transfusion adverse effects Cell Separation methods Leucocyte-poor blood products Leukocytes immunology Blut (DE-588)4007259-9 gnd rswk-swf Leukapherese (DE-588)4238349-3 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Blut (DE-588)4007259-9 s Leukapherese (DE-588)4238349-3 s DE-604 Sweeney, Joseph Sonstige oth DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006785911&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Clinical benefits of leukodepleted blood products Bloedtransfusie gtt Leukocyten gtt Blood Component Transfusion adverse effects Cell Separation methods Leucocyte-poor blood products Leukocytes immunology Blut (DE-588)4007259-9 gnd Leukapherese (DE-588)4238349-3 gnd |
subject_GND | (DE-588)4007259-9 (DE-588)4238349-3 (DE-588)4143413-4 |
title | Clinical benefits of leukodepleted blood products |
title_auth | Clinical benefits of leukodepleted blood products |
title_exact_search | Clinical benefits of leukodepleted blood products |
title_full | Clinical benefits of leukodepleted blood products Joseph Sweeney ... |
title_fullStr | Clinical benefits of leukodepleted blood products Joseph Sweeney ... |
title_full_unstemmed | Clinical benefits of leukodepleted blood products Joseph Sweeney ... |
title_short | Clinical benefits of leukodepleted blood products |
title_sort | clinical benefits of leukodepleted blood products |
topic | Bloedtransfusie gtt Leukocyten gtt Blood Component Transfusion adverse effects Cell Separation methods Leucocyte-poor blood products Leukocytes immunology Blut (DE-588)4007259-9 gnd Leukapherese (DE-588)4238349-3 gnd |
topic_facet | Bloedtransfusie Leukocyten Blood Component Transfusion adverse effects Cell Separation methods Leucocyte-poor blood products Leukocytes immunology Blut Leukapherese Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006785911&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT sweeneyjoseph clinicalbenefitsofleukodepletedbloodproducts |